에 대한 최신 뉴스 Pulse Biosciences (NASDAQ:PLSE) 주식

Pulse Biosciences

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Analyst Color

Broad U.S. Equity ETFs

Small Cap

ETFs

EVGO

IGMS

LNTH

MORF

OUST

PLSE

SOUN

iShares Russell 2000 ETF가 추적하는 러셀(Russell) 2000 소형주 지수는 2023년 10월 이후 최고의 주간 실적을 기록하여 6% 이상 급등하여 2022년 1월 이후 최고 수준에 도달했다.

러셀 2000 지수, 연중 가장 강한 주를 기록하며 31개월 최고치를 기록

Pulse Biosciences Inc

In a quiet week for economic data, Wall Street&#8217;s focus shifted to the possibility of witnessing a "Santa Rally," the seasonal tendency for stocks to rise in the <a href="https://www.benzinga.com/general/education/24/12/42675763/santa-rally-serial-winners-10-stocks-historically-poised-for-big-year-end-gains">final days of December. </a>
Historically, the S&amp;P 500 has gained 64 times in the past 96 years during the Dec. 24–Dec. 31 window, averaging a 0.85% return.
The market began the week attempting a recover from the Federal Reserve's hawkish signals of fewer rate cuts in 2024. Yet, renewed volatility resurfaced on Friday, casting doubt on the Santa rally's resilience.
Investors remain cautious, as markets weigh Fed policy outlook against uncertainty surrounding the incoming Trump administration's economic plans.
Still, 2024 is shaping up to be a banner year. The S&amp;P 500 is on track to match last year's 24% surge, setting up a two-year gain of 55%, the strongest since 1999. U.S. stocks are also outperforming global markets by the widest margin since 1997, driven by the enduring strength of U.S. economic fundamentals.
On the leaderboards, Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) has surged 360%, overtaking Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), last year's top performer, which gained 175% in 2024.
Consumer Confidence Slips
U.S. consumer confidence, as measured by the Conference Board, declined in December, highlighting rising concerns <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42657230/us-consumer-confidence-drops-in-december-expectations-signal-potential-economic-weakness-in-2025">about economic conditions</a>. A deeper drop in the expectations index, a key forward-looking measure, signals potential weakness in 2025 amid fears of persistent inflation and steady, high interest rates.
Tesla's Robotaxi Bet
Elon Musk envisions a Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)&#8217;s robotaxi fleet allowing owners to earn $40,000 annually. Despite the bold prediction, experts question the feasibility of the technology and regulatory challenges, suggesting Musk's vision remains aspirational rather than immediately achievable <a href="https://www.benzinga.com/24/12/42642606/elon-musk-wants-to-raise-a-tesla-fleet-expert-estimates-vehicle-owners-can-make-40kyear-but-remains-doubtful">in the near term.</a>
Trump's Tariff Impact
Goldman Sachs projects the Trump administration will raise tariffs on Chinese imports, averaging a 20% hike, with higher rates for non-consumer goods. This could increase consumer prices by 1%-2%, strain industrial margins, disrupt supply chains and <a href="https://www.benzinga.com/government/regulations/24/12/42701155/made-in-china-paid-in-america-what-trumps-new-tariffs-mean-for-the-us-economy">ignite Chinese retaliatory measures,</a> the Wall Street firm says.
Cadillac EV Success
General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>)&#8217;s Cadillac Lyriq, priced at $60,000, became its best-selling EV in 2024 through the third quarter. The premium EV's success highlights a potential shift toward luxury electric vehicles as automakers target higher <a href="https://www.benzinga.com/tech/24/12/42666472/gms-60000-cadillac-lyriq-was-its-best-selling-ev-in-2024-as-of-q3-is-premium-the-way-to-go-for-ev-makers">margins and affluent buyers.</a>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/12/42710358/veteran-investor-bets-big-on-sp-500-hitting-7000-by-end-of-2025-these-sectors-could-lead-the-charge">Veteran Investor Bets Big On S&amp;P 500 Hitting 7,000 By End Of 2025: These Sectors Could Lead The Charge</a></li>
</ul>
Photo by Marek Maskin on Shutterstock

Equities

Large Cap

Macro Economic Events

Econ #s

Economics

Federal Reserve

Tech

NVDA

PLTR

TSLA

Wall Street's Santa Rally At Risk, Palantir Dethrones Nvidia, Consumer Confidence Pulls Back: This Week In The Markets

Vistra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) has outperformed the market over the past 5 years by 30.38% on an annualized basis producing an average annual return of 43.46%. Currently, Vistra has a market capitalization of $47.52 billion. 
Buying $1000 In VST: If an investor had bought $1000 of VST stock 5 years ago, it would be worth $6,120.95 today based on a price of $139.68 for VST at the time of writing.
<h3>Vistra's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735335008_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

$1000 Invested In Vistra 5 Years Ago Would Be Worth This Much Today

VINC

Trading Halt: Halt status updated at 4:25:00 PM ET: Quotation Resumption: News and Resumption Times

Centene (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) has outperformed the market over the past 15 years by 5.77% on an annualized basis producing an average annual return of 17.46%. Currently, Centene has a market capitalization of $30.59 billion. 
Buying $100 In CNC: If an investor had bought $100 of CNC stock 15 years ago, it would be worth $1,117.05 today based on a price of $60.60 for CNC at the time of writing.
<h3>Centene's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735334113_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Centene Stock In The Last 15 Years

Management

Vincerx Implements Workforce Reduction Amid Strategic Streamlining; CEO Ahmed Hamdy Steps Down, Raquel Izumi Named Acting CEO, And Kevin Hass Takes Over As Acting CFO As Leadership Transitions Support Ongoing Strategic Efforts

<h3>Gainers</h3>
<ul>
<li>Ambow Education Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMBO#AMEX">AMBO</a>) shares moved upwards by 38.4% to $3.1 during Friday's pre-market session. The company's market cap stands at $8.7 million. </li>
<li>Solid Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDP#NASDAQ">SLDP</a>) shares increased by 37.89% to $2.69. The company's market cap stands at $485.0 million. </li>
<li>Luminar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) stock rose 14.96% to $6.3. The market value of their outstanding shares is at $209.7 million. </li>
<li>Nxu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXU#NASDAQ">NXU</a>) stock increased by 13.2% to $0.3. The market value of their outstanding shares is at $4.6 million. </li>
<li>Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) stock increased by 13.16% to $0.49. The company's market cap stands at $31.7 million. </li>
<li>Premium Catering (Hldgs) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PC#NASDAQ">PC</a>) stock moved upwards by 12.99% to $0.82. The company's market cap stands at $13.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) stock declined by 11.6% to $0.46 during Friday's pre-market session. The market value of their outstanding shares is at $10.8 million. </li>
<li>Boqii Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BQ#AMEX">BQ</a>) shares decreased by 8.14% to $0.34. The company's market cap stands at $1.5 million. </li>
<li>Mixed Martial Arts Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) stock fell 6.29% to $1.64. The company's market cap stands at $17.1 million. </li>
<li>JX Luxventure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JXG#NASDAQ">JXG</a>) stock declined by 5.92% to $0.89. The company's market cap stands at $5.3 million. </li>
<li>Global Business Travel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBTG#NYSE">GBTG</a>) shares fell 5.86% to $9.0. The company's market cap stands at $4.2 billion. </li>
<li>Brilliant Earth Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRLT#NASDAQ">BRLT</a>) stock fell 5.42% to $1.92. The market value of their outstanding shares is at $26.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ALUR

AMBO

BRLT

GBTG

LAZR

SLDP

XELB

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

Vincerx Pharma Announces Binding Term Sheet For Strategic Merger With Oqory, Inc.; Oqory Equity Holders To Own 95% Of Combined Entity, Vincerx 5%; Merger Includes $13.66M Equity Value For Vincerx Stockholders And $20M Equity Financing Requirement

<h3>Gainers</h3>
<ul>
<li>Quantum-Si (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) stock moved upwards by 60.0% to $3.44 during Friday's pre-market session. The market value of their outstanding shares is at $605.0 million. </li>
<li>Evaxion Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) shares increased by 39.47% to $1.18. The market value of their outstanding shares is at $6.9 million. </li>
<li>Serina Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SER#AMEX">SER</a>) stock moved upwards by 32.76% to $7.01. The company's market cap stands at $62.3 million. </li>
<li>DIH Holding US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAI#NASDAQ">DHAI</a>) stock moved upwards by 25.42% to $1.48. The company's market cap stands at $60.0 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) shares rose 18.01% to $0.99. The market value of their outstanding shares is at $67.9 million. </li>
<li>Tiziana Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSA#NASDAQ">TLSA</a>) shares moved upwards by 14.35% to $0.8. The market value of their outstanding shares is at $83.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) stock declined by 20.8% to $8.4 during Friday's pre-market session. The market value of their outstanding shares is at $569.8 million. </li>
<li>Nutex Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUTX#NASDAQ">NUTX</a>) shares fell 11.83% to $29.0. The company's market cap stands at $157.6 million. </li>
<li>Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) stock declined by 11.45% to $4.95. The company's market cap stands at $5.5 million. </li>
<li>Viracta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRX#NASDAQ">VIRX</a>) stock declined by 10.38% to $0.21. The market value of their outstanding shares is at $8.4 million. </li>
<li>Procaps Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROC#NASDAQ">PROC</a>) shares decreased by 9.32% to $2.24. The company's market cap stands at $252.7 million. </li>
<li>Carmell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) stock decreased by 8.42% to $0.29. The market value of their outstanding shares is at $6.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTCX

DHAI

EVAX

NUTX

PHAR

PROC

PRTG

TLSA

VIRX

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) shares increased by 64.1% to $2.33 during Friday's pre-market session. The market value of their outstanding shares is at $833.2 million. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares rose 31.69% to $0.55. The company's market cap stands at $67.4 million. </li>
<li>Odyssey Marine Explr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMEX#NASDAQ">OMEX</a>) shares increased by 27.9% to $0.61. The company's market cap stands at $17.8 million. </li>
<li>Nauticus Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) shares moved upwards by 23.03% to $2.19. The market value of their outstanding shares is at $14.0 million. </li>
<li>CBAK Energy Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBAT#NASDAQ">CBAT</a>) stock rose 22.73% to $1.12. The company's market cap stands at $100.7 million. </li>
<li>Zeo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) shares rose 21.53% to $3.16. The market value of their outstanding shares is at $43.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Quest Resource Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRHC#NASDAQ">QRHC</a>) shares decreased by 19.0% to $5.02 during Friday's pre-market session. The market value of their outstanding shares is at $102.3 million. </li>
<li>Markforged Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKFG#NYSE">MKFG</a>) shares declined by 8.03% to $2.98. The market value of their outstanding shares is at $61.4 million. </li>
<li>Gencor Industries (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GENC#AMEX">GENC</a>) stock declined by 7.4% to $16.85. The company's market cap stands at $247.0 million. </li>
<li>Mynaric (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares declined by 6.95% to $0.43. The market value of their outstanding shares is at $10.8 million. </li>
<li>XCHG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCH#NASDAQ">XCH</a>) shares declined by 6.67% to $2.24. The market value of their outstanding shares is at $133.1 million. </li>
<li>Nocera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCRA#NASDAQ">NCRA</a>) shares decreased by 6.23% to $0.93. The company's market cap stands at $13.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CBAT

GENC

KITT

MKFG

MYNA

NCRA

OMEX

QRHC

12 Industrials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) shares increased by 359.9% to $2.07 during Friday's pre-market session. The market value of their outstanding shares is at $18.0 million. </li>
<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) shares rose 112.08% to $8.95. The market value of their outstanding shares is at $11.2 million. </li>
<li>iLearningEngines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) stock rose 102.6% to $0.33. The market value of their outstanding shares is at $46.1 million. </li>
<li>T Stamp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDAI#NASDAQ">IDAI</a>) shares rose 50.0% to $0.81. The market value of their outstanding shares is at $20.4 million. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock moved upwards by 40.62% to $1.8. The market value of their outstanding shares is at $16.4 million. </li>
<li>Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) stock moved upwards by 21.61% to $1.24. The market value of their outstanding shares is at $116.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Castellum (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CTM#AMEX">CTM</a>) stock fell 11.6% to $1.22 during Friday's pre-market session. The market value of their outstanding shares is at $68.4 million. </li>
<li>ReAlpha Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) stock fell 9.22% to $3.25. The market value of their outstanding shares is at $149.0 million. </li>
<li>Sigmatron Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMA#NASDAQ">SGMA</a>) stock fell 8.34% to $1.54. The market value of their outstanding shares is at $9.4 million. </li>
<li>Silvaco Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVCO#NASDAQ">SVCO</a>) shares fell 7.69% to $7.57. The company's market cap stands at $215.4 million. </li>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) stock fell 5.97% to $2.68. The company's market cap stands at $26.7 million. </li>
<li>Saiheat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIH#NASDAQ">SAIH</a>) shares declined by 5.65% to $0.7. The market value of their outstanding shares is at $17.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AILE

AIRE

IDAI

INTZ

LIDR

MLGO

MYSZ

REKR

SAIH

SGMA

SVCO

12 Information Technology Stocks Moving In Friday's Pre-Market Session

Earnings

CCTG

CCSC Technology International H1 2025 Revenue $9.2M Vs $7.5M YoY; EPS $(0.06) Vs $(0.04) YoY

WIIM

CCSC Technology International Holdings shares are trading higher after the company reported financial results for the first six months of FY25.

Trading Halt: Halted at 4:01:00 p.m. ET - Trading Halt: Halt News Pending

Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) has outperformed the market over the past 20 years by 2.91% on an annualized basis producing an average annual return of 11.28%. Currently, Autodesk has a market capitalization of $63.99 billion. 
Buying $1000 In ADSK: If an investor had bought $1000 of ADSK stock 20 years ago, it would be worth $7,932.54 today based on a price of $296.92 for ADSK at the time of writing.
<h3>Autodesk's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735332959_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADSK

Here's How Much $1000 Invested In Autodesk 20 Years Ago Would Be Worth Today

The S&amp;P 500 index is set to end 2024 with its strongest edge over global equities in nearly 30 years, a remarkable streak fueled <a href="https://www.benzinga.com/news/econ-s">by U.S. economic dominance. </a>
Yet, Bank of America analysts caution that the rally's days may be numbered, predicting a reversal as early as the second quarter of 2025.
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) has surged 25% year-to-date as of Dec. 27, delivering a 21-percentage-point edge over global equities excluding U.S. exposure, tracked by the iShares MSCI ACWI ex U.S. ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACWX#NYSE">ACWX</a>)
That marks the widest outperformance of American versus world equities since 1997. 
This is also the widest performance gap since 1997, driven by investor positioning for &#8220;Trump trades&#8221; of higher U.S. dollar, equities and bond yields, according to Bank of America&#8217;s chief investment strategist Michael Hartnett.
Hartnett predicts that an &#8220;inflation boom&#8221; in the U.S. combined with a &#8220;global deflation bust&#8221; will drive a first-quarter overshoot in U.S. stocks. 
&#8220;We believe US small cap&nbsp;(Russell 2000)&nbsp;is the&nbsp;best trade to&nbsp;position for&nbsp;overshoots,&#8221; Hartnett said in a recent report. 
Hartnett highlighted that global equity markets are heading into 2025 with significantly weak economic momentum, especially in manufacturing &#8211; and this is even before factoring in the potential impact of a trade war.
But, as the champagne flows this New Year's Eve, Bank of America analysis suggests a sobering reality may await from the second quarter of 2025.
<h3 class="wp-block-heading">Chart: S&amp;P 500 Sharply Outperformed International Equities In 2024</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="557" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27152453/image-222-1024x557.png" alt="" class="wp-image-709750" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27152453/image-222-1024x557.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27152453/image-222-300x163.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27152453/image-222-768x418.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27152453/image-222-1536x835.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27152453/image-222.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">A Shift To International Markets?</h3>
By spring 2025, Bank of America forecasts a hawkish Federal Reserve and &#8220;policy panic&#8221; in Europe and Asia to trigger a peak in U.S. market &#8220;exceptionalism.&#8221; 
According to Hartnett a strong U.S. dollar, already near multi-year highs, contributed to U.S. stocks' outperformance but poses risks given that 30% of S&amp;P 500 revenues come from overseas markets.
Hartnett projects that aggressive fiscal easing in China, new European stimulus – boosted by potential German election outcomes – and rate cuts by the European Central Bank will create fertile ground for global equities.
This could lead to significant rotations into international equities and currencies. 
"By Q2, we anticipate lower interest rates, cheaper currencies, and fiscal easing in Europe and China," Hartnett said.
Emerging markets, battered by a strong dollar and trade uncertainty, may finally rebound as the greenback loses steam.
David Hauner, head of global emerging markets fixed income strategy at Bank Of America, remains cautious on emerging markets in the near term but sees buying opportunities as U.S. trade policies become clearer and the dollar reaches a turning point.
<h3 class="wp-block-heading">2025: Volatility And Opportunity</h3>
Savita Subramanian, Bank of America&#8217;s head of U.S. equity strategy, said potential Trump 2.0 policies could heighten inflation and deficit risks.
&#8220;Trump 2.0 may drive higher uncertainty around inflation and deficit risks.&nbsp;Immigration and tariffs may be inflationary, but corporate tax cuts are disinflationary as benefits get passed onto the consumer,&#8221; Subramanian said.
She highlighted the prospects for a strong GDP upcycle, driven by lighter regulations and increased energy production lowering oil prices.
Despite predictions of volatility return in 2025, Bank of America analysts remain bullish on the S&amp;P 500. 
They indicated an ambitious year-end target of 6,666 for 2025, marking a staggering 10x rally from the market's 2009 lows.
"Volatility will present opportunities to buy the S&amp;P 500 at lower levels in 2025," said Subramanian, adding that the index is likely to close the year higher than current levels.
Read now: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/12/42701155/made-in-china-paid-in-america-what-trumps-new-tariffs-mean-for-the-us-economy">Made In China, Paid In America: What Trump&#8217;s New Tariffs Mean For The US Economy</a></li>
</ul>
Photo: Shutterstock

Guidance

Eurozone

Analyst Ratings

ACWX

S&P 500 Poised For Best Year Vs. Global Stocks Since 1997: Bank Of America Warns Of 2005 Rotation

GDS Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) are trading higher Friday amid continued interest sparked by reports that the company is evaluating an initial public offering (IPO) for its<a href="https://www.benzinga.com/quote/GDS/news"> data center assets in China.</a>
What To Know: Sources familiar with the matter, who requested anonymity due to the private nature of the discussions, indicated that GDS is collaborating with advisers to gauge investor interest in the potential IPO, <a href="https://www.bloomberg.com/news/articles/2024-12-24/data-center-operator-gds-is-said-to-consider-ipo-of-china-reit">according to Bloomberg.</a> 
The proposed real estate investment trust (REIT) could generate proceeds of approximately 1 billion yuan, equivalent to about $140 million. However, the deliberations are still in preliminary stages and the possibility remains that no final transaction will occur. The company has not provided any official comment on the matter.
Over the past year, the Chinese government has relaxed rules regarding the eligibility of assets for inclusion in REITs, a move that analysts believe could establish China as a significant player in the global commercial property trust market. Since these regulatory changes, 13 REIT IPOs have been priced in China. Furthermore, the China Securities Regulatory Commission is reportedly working on incorporating REITs into the Hong Kong Stock Connect program, a move designed to increase exposure to offshore investors.
The company also announced a $1.2 billion Series B funding round for its international data centers. Notable participants in this round included Coatue Management, SoftBank Vision Fund and Ken Griffin, CEO of Citadel. This funding underscores GDS's broader strategy to position itself as a major player in the global data center space while leveraging favorable developments in the REIT market domestically.
GDS Price Action: GDS Holdings shares were up 7.38% at $22.18 at publication Friday, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="511" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27142803/Screenshot-2024-12-27-at-14.27.25-1024x511.png" alt="" class="wp-image-709691" style="width:528px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27142803/Screenshot-2024-12-27-at-14.27.25-1024x511.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27142803/Screenshot-2024-12-27-at-14.27.25-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27142803/Screenshot-2024-12-27-at-14.27.25-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27142803/Screenshot-2024-12-27-at-14.27.25-1536x767.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27142803/Screenshot-2024-12-27-at-14.27.25.png 1538w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/24/12/42709387/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Yet</a></li>
</ul>
Photo: Shutterstock.

REIT

Global

Real Estate

GDS Holdings Shares Are Up Today: What You Need To Know

In the current session, Adobe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) is trading at $447.22, after a 0.65% decrease. Over the past month, the stock decreased by 13.71%, and in the past year, by 23.25%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2024/1735332319_0.png" alt="Past Year Chart" />

<h3>Adobe P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 96.7 in the Software industry, Adobe Inc. has a lower P/E ratio of 36.42. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1735332319_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

ADBE

P/E Ratio Insights for Adobe

<h2 class="wp-block-heading">Bankruptcy Block</h2>
Party City Holdco Inc., the one-stop-shop for all things celebration, is calling it a wrap. The company&#8217;s 700 stores are holding going-out-of-business sales. 
This is the second time Party City filed for Chapter 11 bankruptcy protection in two years. In 2023, a restructuring process eliminated almost $1 billion in debt — not enough to keep the party going.
Party City also faced some serious buzzkills like inflation and, per a New York Post <a href="https://nypost.com/2023/01/25/party-citys-founder-blames-bankruptcy-on-private-equity-firms/">interview</a> with the chain&#8217;s founder, Steve Mandell, shoddy leadership.
Party City is owned by investment firms such as Capital Group, Davidson Kempner and Silver Point Capital.
The Woodcliff Lake, New Jersey-based company filed for Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
Over 95% of Party City's 12,000 employees will stay on until <a href="https://www.cnn.com/2024/12/20/business/party-city-shut-down/index.html">Feb. 28</a> to help with the big cleanup.
The news of Party City&#8217;s demise came just days after bankrupt retailer Big Lots (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BIGGQ#OTC">BIGGQ</a>) <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42624759/big-lots-holds-liquidation-sales-analyst-pegs-competitor-as-major-beneficiary-market-share-capture-opportunity">failed to find a buyer</a>.
The retailer previously announced it was selling its assets to private equity firm Nexus Capital Management back in September. But now the deal is pretty much off the table.
In true clearance-sale spirit, the company is launching its "going out of business" blowout. It's also keeping hope alive by exploring other options. Whether that's cajoling Nexus back to the table or finding a new buyer remains to be seen. 
That&#8217;s not all. <a href="https://www.benzinga.com/news/asset-sales/24/11/42254293/deal-dispatch-stoli-bankrupt-ally-financial-to-sell-credit-card-unit">Benzinga Deal Dispatch reported</a> last month The Container Store was on the verge of bankruptcy. Recall how it was unable <a href="https://www.benzinga.com/markets/equities/24/10/41356027/whats-going-on-with-container-store-stock-after-getting-40m-investment-from-beyond">to ink a deal</a> with Beyond Inc. The <a href="https://www.businesswire.com/news/home/20241222725949/en/The-Container-Store-to-Execute-Comprehensive-Recapitalization-Transaction-with-Lender-Support-to-Best-Position-the-Company-for-Future-Success">filing</a> became official on Sunday, Dec. 22, in a Texas district court.
But unlike Party City and Big Lots, The Container Store is staying in business.
&#8220;Our strategy is sound,&#8221; said The Container Store CEO Satish Malhotra. 
The beloved storage solutions and in-home services provider is tidying up its finances. Up to 90% of the company's term loan lenders have jumped on board with a transaction support agreement. 
The Container Store will have $40 million in fresh funds and $45 million in debt reduction. All this means The Container Store is aiming keep its promises to partners, vendors and stakeholders without a hitch. 
The company expects to exit bankruptcy within the next 30 days. When it re-emerges, it will be a private company.
The Container Store&#8217;s Elfa business in Sweden remains unaffected. 
See Also: <a href="https://www.benzinga.com/24/12/42710061/cannabis-reform-2024-the-year-of-all-talk-and-no-action">Cannabis Reform 2024 — The Year Of All Talk And No Action</a>
<h2 class="wp-block-heading">New On The Block</h2>
Viracta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRX#NASDAQ">VIRX</a>) is considering a sale. The oncology company — focused on virus-associated cancers — announced the process as part of a strategic review. Viracta voluntarily closed its pivotal Phase 2 NAVAL-1 trial of Nana-val for relapsed/refractory EBV+ lymphomas, citing no new safety concerns. CEO Mark Rothera remains optimistic about Nana-val&#8217;s future approval. 
<h2 class="wp-block-heading">Updates From The Block</h2>
Buyout firm TPG is in talks to acquire Altus Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPS#NYSE">AMPS</a>), a solar energy provider to commercial property owners and residential homes, Reuters reported on Dec. 23. A competing bid could emerge. 
Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>)&nbsp;<a href="https://www.benzinga.com/news/24/12/42680655/alibaba-nears-4b-e-commerce-merger-with-south-koreas-e-mart-report">is close to merging</a>&nbsp;its South Korean operations with&nbsp;E-Mart Inc.&nbsp;in a deal valued at approximately $4 billion. This strategic move aims to bolster their position in South Korea&#8217;s competitive online retail market. The potential joint venture would combine the e-commerce assets of both companies. Discussions are ongoing, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-12-26/alibaba-is-said-to-near-4-billion-deal-with-korea-s-e-mart">reported</a>&nbsp;on Thursday.
<h2 class="wp-block-heading">Notes From The Block</h2>
In 2024, private equity and financial investors showed renewed interest, according to Bain &amp; Co. Deal value increased by 29% year-over-year due to <a href="https://www.benzinga.com/topic/interest-rates">slightly lower interest rates</a>.
Corporate M&amp;A, less impacted by minor debt cost changes, is projected to finish the year 12% higher than 2023, with a 7% rise in deal volume across all regions, the firm noted.
&#8220;Overall, the level of M&amp;A activity was a middling $3.5 trillion,&#8221; the firm <a href="https://www.bain.com/insights/looking-back-m-and-a-report-2025/">noted</a>. &#8220;That&#8217;s a number consistent with what we saw in the mid-2010s.&#8221;
For last week&#8217;s <a href="https://www.benzinga.com/news/rumors/24/12/42635878/deal-dispatch-honeywell-textron-soho-house-m-and-a-moves">Deal Dispatch, click here</a>. 
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42701686/bitcoin-could-slide-to-60000-technical-analyst-warns">Bitcoin Could Slide To $60,000, Technical Analyst Warns</a></li>
</ul>

Asset Sales

Legal

AMPS

BABA

BIGGQ

COEP

CPNG

Deal Dispatch: Party City Wraps Up, Big Lots Goes Bust, The Container Store Continues

Siyata Mobile Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) shares are trading higher on Friday, possibly following the company&#8217;s announcement of a 1-for-10 <a href="https://www.benzinga.com/pressreleases/24/12/n42669127/siyata-announces-reverse-stock-split">reverse stock split on Tuesday.</a>
What To Know: The move is aimed at maintaining compliance with Nasdaq&#8217;s $1 minimum bid price requirement. The reverse stock split will be effective on Dec. 27, 2024, with trading on a post-split basis commencing the same day under the ticker symbol &#8220;SYTA.&#8221;
The reverse stock split consolidates every 10 existing shares into one new share. Outstanding stock options, warrants and other convertible securities will also be adjusted to reflect the new ratio. No fractional shares will be issued, with fractions rounded up to the nearest whole number.
Siyata, a global provider of Push-to-Talk over Cellular devices and cellular signal boosters, clarified that the split does not affect the par value or authorized number of shares. The transfer agent, Computershare, will handle the exchange process for registered shareholders. Those holding shares electronically or through brokers will have their positions adjusted automatically.
Despite the stock price jump, the company warned there is no guarantee it will maintain compliance with the minimum bid price requirement after the split.
SYTA Price Action: Siyata Mobile shares were up 23.62% at $6.43 at publication Friday, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="530" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27145904/Screenshot-2024-12-27-at-14.58.08-1024x530.png" alt="" class="wp-image-709735" style="width:463px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27145904/Screenshot-2024-12-27-at-14.58.08-1024x530.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27145904/Screenshot-2024-12-27-at-14.58.08-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27145904/Screenshot-2024-12-27-at-14.58.08-768x398.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27145904/Screenshot-2024-12-27-at-14.58.08.png 1528w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42709939/apple-teases-streaming-see-for-yourself-event-could-this-be-a-free-preview-of-appletv-or-ad-supported-platform"> Apple Teases Streaming &#8216;See For Yourself&#8217; Event: Could This Be A Free Preview Of AppleTV+ Or Ad-Supported Platform?</a></li>
</ul>
Photo: Shutterstock

Stock Split

SYTA

Siyata Mobile Shares Are On The Rise Friday: What's Going On?

After a surge in betting on prediction markets for outcomes of events like the 2024 U.S. presidential election, the next market that is generating plenty of interest and concern from regulators is the outcome of the murder<a href="https://www.benzinga.com/24/12/42541669/luigi-mangione-faces-murder-first-degree-life-in-prison-in-ceo-death-a-senseless-act-of-violence"> trial of Luigi Mangione.</a>
What Happened: Mangione <a href="https://www.benzinga.com/24/12/42655562/luigi-mangione-suspected-ceo-assassin-pleads-not-guilty-in-new-york-court">recently pleaded not guilty</a> to New York state charges that include murder in the first degree of UnitedHealthcare CEO Brian Thompson.
Recently extradited from Pennsylvania to New York, Mangione also faces federal charges that could lead to a death penalty sentence if he is found guilty.
Mangione&#8217;s story has captured plenty of attention in America as evidence linked the killing of Thompson, who was CEO of the insurance company owned by UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), to Mangione allegedly<a href="https://www.benzinga.com/24/12/42605759/luigi-mangione-faces-death-penalty-details-show-attack-planned-for-months-the-target-is-insuranceit-checks-every-box"> targeting the health insurance sector</a> that he viewed as putting greed ahead of consumer health.
Ahead of Mangione's extradition and court hearings, people in the U.S. and around the world have been able to bet on the outcomes thanks to the rise of prediction markets.
Kalshi, which is regulated by the Commodity Futures Trading Commission, took wagers on several items beginning on Nov. 11 and bragged about the numerous markets on social media platform X.
Among the Kalshi markets: whether Mangione would be extradited, whether he would plead guilty, if he would be convicted, if he or a family member had insurance with UnitedHealthcare and whether he acted alone in the alleged murder of Thompson.
Kalshi <a href="https://kalshi.com/markets/kxuhcplea/luigi-guilty-plea">halted </a>the Mangione markets, but they can still be found on the website through a search. The markets are listed as "paused." Kalshi has put the blame for the halt in the hands of regulators, according to a report from <a href="https://www.bloomberg.com/news/articles/2024-12-27/bets-on-ceo-murder-suspect-s-fate-test-rules-on-event-contracts?sref=TBDibEcD">Bloomberg</a>.
The CFTC bans futures trading for war, terrorism and crimes like assassinations, according to the report.
Prediction market Polymarket has multiple <a href="https://polymarket.com/markets?_q=luigi+mangione">markets </a>open connected to the Mangione case, including whether a YouTube channel connected to him is real, if he was a lone actor, if he will fire his lawyer, whether his parents were UnitedHealthcare customers and if he used psychedelics.
Polymarket is not regulated in the United States. On Polymarket, users can deposit funds using USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) via the Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/matic/usd">MATIC</a>) network or can deposit directly from a crypto account with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>).
BetUS, which is regulated in certain territories, is <a href="https://press.betus.com.pa/245601-betus-offers-odds-on-the-luigi-mangione-case">offering </a>betting odds on several Mangione-related outcomes like whether he will plead guilty before May 31, 2025. The betting odds are set at -350 for No and +225 for Yes. BetUS also said it will offer lines on whether Mangione used psychedelics and if he will fire his lawyer in 2025.
Read Also: <a href="https://www.benzinga.com/news/legal/24/12/42418763/unitedhealthcare-ceo-murder-suspect-chronic-pain-unabomber-fascination-isolation-details-emerge">UnitedHealthcare CEO Murder Suspect: Chronic Pain, Unabomber Fascination, Isolation Details Emerge</a>
Why It's Important: Mangione's case has led to plenty of support from the public due to hatred for the health insurance industry by some, an item<a href="https://www.benzinga.com/media/24/12/42473433/joe-rogan-on-public-sympathy-for-unitedhealthcare-ceo-murder-suspect-health-insurance-a-dirty-dirty-business"> touched on by</a> popular podcaster Joe Rogan. 
Supporters have shown up outside courtrooms with signs backing the alleged murderer. The mention of Mangione on a recent episode of "Saturday Night Live" led members of the audience to cheer at his name.
Prediction markets have risen in popularity thanks to the 2024 election and are able to offer markets quickly on a variety of topics and viral news stories.
When it comes to murder cases, there will likely be push back from regulators and members of the public who see a moral obligation to avoid profiting from bad actors. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/12/42544499/luigi-mangione-documentaries-in-the-works-from-award-winning-creators-and-possibly-rapper-50-cent">Luigi Mangione Documentaries In The Works From Award-Winning Creators — And Possibly Rapper 50 Cent</a></li>
</ul>
Luigi Mangione photo courtesy of Pennsylvania State Police.

Government

Regulations

$ETH

$MATIC

$USDC

Can You Bet On Luigi Mangione's Fate? Betting Platforms, Regulators Wrestle With Limits In Growing Market

Pulse Biosciences Inc ( ($PLSE) ) has realeased its Q3 earnings. Here is a breakdown of the information Pulse Biosciences Inc presented to its inve...

Pulse Biosciences Reports Q3 2024 Financials and Developments

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pulse Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/plse-stock-quote/">PLSE</a>) just reported results for the second quarter of 2024.<ul><li>Pulse Biosciences reported earnings per share of -20 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	The post <a href="https://investorplace.com/earning-results/2024/08/plse-stock-earnings-pulse-biosciences-for-q2-of-2024/">PLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

PLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024

Pulse Biosciences (PLSE) announced "positive preliminary results" from its first-in-human feasibility study using Nanosecond Pulsed Field Ablation ...

Pulse Biosciences announces 'positive' clinical data presented at meeting

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pulse Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/plse-stock-quote/">PLSE</a>) just reported results for the second quarter of 2024.<ul><li>Pulse Biosciences reported earnings per share of -20 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	
	The post <a href="https://investorplace.com/earning-results/2024/08/plse-stock-earnings-pulse-biosciences-for-q2-of-2024/">PLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

The latest announcement is out from Pulse Biosciences ( ($PLSE) ). Robert W. Duggan, the controlling stockholder and Co-Chairman of Pulse Bioscienc...

Pulse Biosciences' Co-Chairman Plans Major Stock Purchase

An announcement from Pulse Biosciences ( ($PLSE) ) is now available. Pulse Biosciences, Inc. announced the resignation of CEO Burke T. Barrett, wit...

Pulse Biosciences CEO Resigns Amid Leadership Transition

Pulse Biosciences: Constructive On Nano-Pulse Assets

Press Releases

Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System

Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors

Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results

Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024

Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology

Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results

Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association

Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery

Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

Artivion

Alphatec Holdings

AtriCure

Axogen

Butterfly Network, Inc. Class A Common Stock

Butterfly Network

CeriBell

ClearPoint Neuro

Conmed

Enovis

Paragon 28

Integra LifeSciences Holdings Corporation - Common Stock

Integra Lifesciences

iRadimed

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies

LeMaitre Vascular

Orthofix Medical

Omnicell

QuidelOrtho

SI-BONE

Semler Scientific

Surmodics

Tactile Systems Technology, Inc. - Common Stock

Tactile Systems Tech

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts

TransMedics Gr

Tandem Diabetes Care, Inc. - Common Stock

Tandem Diabetes Care

Varex Imaging

Stephens & Co.

iShares Russell 2000 ETF가 추적하는 러셀(Russell) 2000 소형주 지수는 2023년 10월 이후 최고의 주간 실적을 기록하여 6% 이상 급등하여 <a href="https://www.benzinga.com/topic/small-caps" target="_blank" rel="noopener" data-google-interstitial="false">2022년 1월 이후</a> 최고 수준에 도달했다.
이러한 랠리는 주로 목요일 세션에 의해 주도되었으며, 러셀 2000 지수는 일일 3.6%라는 놀라운 상승률을 기록했다. 이번 급등은 예상보다 낮은 6월 인플레이션 데이터에 따른 것이며, 이로 인해 잠재적인 금리 인하 가능성에 대한 기대가 강화되었다.
그러나 LPL 파이낸셜의 최고 글로벌 전략가인 퀸시 크로스비(Quincy Krosby)는 러셀 2000의 금리 인하 메시지가 &#8220;노동 시장에 대한 연방준비제도(연준)의 우려로 인해 흐려질 수 있다&#8221;고 시사하면서 주의를 조언했다.
크로스비는 노동시장 약화가 경제적으로 민감한 러셀 2000 지수에 여전히 타격을 줄 것이며, 금리 인하가 반드시 더 광범위한 경기 둔화로부터 지수를 보호할 수는 없을 것이라고 생각한다.
<h2 class="wp-block-heading">이번 주의 차트: 8개월 만에 최대 성과를 올린 소형주 지수</h2>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" class="wp-image-434094" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/12145314/Screenshot-2024-07-12-alle-20.34.21-1024x488.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/12145314/Screenshot-2024-07-12-alle-20.34.21-1024x488.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/12145314/Screenshot-2024-07-12-alle-20.34.21-300x143.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/12145314/Screenshot-2024-07-12-alle-20.34.21-768x366.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/12145314/Screenshot-2024-07-12-alle-20.34.21-1536x732.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/12145314/Screenshot-2024-07-12-alle-20.34.21.png 1920w" alt="" width="1024" height="488" /></figure>
출처: <a href="URL http://www.benzinga.com/pro/register/?utm_source=BZprocontent071224&amp;t=be2bearmibe3na1">Benzinga Pro</a>
러셀 2000의 인상적인 성과는 투자자들이 거대 기술 기업들에서 벗어나 더 넓은 시장으로 직접 유입됨에 따라 금리에 민감한 중소형주가 이익을 얻는 등 시장 초점의 상당한 변화를 강조한다고 크로스비가 강조했다.
이 분석가는 러셀 2000이 잠재적인 금리 완화와 광범위한 경제 상황에 대한 중요한 지표 역할을 한다고 지적했다. 일반적으로 중소형주 유니버스는 매력적인 밸류에이션에도 불구하고 심각한 경기 둔화 조짐이 보이면 매도할 것이다.
"역사적으로 러셀 2000은 첫 번째 금리 인하 이후 3개월 동안 시장보다 뒤쳐졌다. 연준이 일반적으로 경제, 특히 노동 시장에 대한 우려로 금리를 인하하기 때문이다. 파월 의장은 연준의 최대 고용 의무화를 계속해서 주장하면서 연준이 경제 지원을 위해 더 빠른 속도로 금리를 인하할 것이라는 점을 분명히 했다"고 그녀가 말했다.
노동 시장 상황이 악화되면 연준은 예정된 9월 18일 회의보다 더 빨리 완화 주기를 시작할 수도 있다고 크로스비는 말했다. 시장에서는 경기 호조 속에서 인플레이션 완화에 따른 금리 인하를 선호하고 있다.
<h2 class="wp-block-heading">이번 주 러셀 2000에서 가장 높은 성과를 기록한 상위 10개 회사 </h2>
<ol>
<li>모픽 홀딩 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MORF#NASDAQ">MORF</a>): 75.16% (헬스케어)</li>
<li>랜티우스 홀딩스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNTH#NASDAQ">LNTH</a>): 55.47% (헬스케어)</li>
<li>IGM 바이오사이언스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGMS#NASDAQ">IGMS</a>): 54.22% (헬스케어)</li>
<li>사운드하운드 AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>): 52.63% (정보기술)</li>
<li>메소드 일렉트로닉스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEI#NASDAQ">MEI</a>): 47.96% (정보기술)</li>
<li>솔라리스 오일필드 인프라스트럭처 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOI#NYSE">SOI</a>): 46.87% (에너지)</li>
<li>펄스 바이오사이언스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLSE#NASDAQ">PLSE</a>): 45.98% (헬스케어)</li>
<li>아우스터 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>): 44.21% (정보기술)</li>
<li>EV고 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGO#NASDAQ">EVGO</a>): 42.65% (소비자 자유롭게 선택 가능한 소비재)</li>
<li>선런 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>): 42.51% (산업재)</li>
</ol>
지금 읽기:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39750466/us-consumer-morale-dips-more-than-expected-in-july-sentiment-remains-stubbornly-subdued">미국 소비자 심리, 7월 예상보다 감소&#8230;전망은 &#8216;완고하게 억제된 상태&#8217;</a></li>
</ul>
사진: 셔터스톡
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Pulse Biosciences

뉴스

에 대한 최신 뉴스 Pulse Biosciences (NASDAQ:PLSE) 주식

금요일, 7월 12, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌